Answer
Patients taking ponesimod should avoid unprotected sunlight exposure because of a potential risk of skin malignancies, and should not receive concurrent UV-B phototherapy or PUVA photochemotherapy.
Sources for this answer
- Ponvory 20 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked